...
首页> 外文期刊>Pediatric Research >334 CEREBROSPINAL FLUID (CSF) 6 INTERFERON (INF) TUMOUR NECROSIS FACTOR-|[alpha]| (TNF) AND INTERLEUKIN-1|[beta]| (1L-l|[beta]|) CONCENTRATIONS IN CHILDREN WITH TUBERCULOUS MENINGITIS (TBM)
【24h】

334 CEREBROSPINAL FLUID (CSF) 6 INTERFERON (INF) TUMOUR NECROSIS FACTOR-|[alpha]| (TNF) AND INTERLEUKIN-1|[beta]| (1L-l|[beta]|) CONCENTRATIONS IN CHILDREN WITH TUBERCULOUS MENINGITIS (TBM)

机译:334脑脊髓液(CSF)6干扰素(INF)肿瘤坏死因子-|α| (TNF)和白细胞介素-1 |β|患有结核性脑膜炎(TBM)的儿童的(1L-1 |β|)浓度

获取原文
   

获取外文期刊封面封底 >>

       

摘要

CSF INF concentrations were determined on 76 occasions in 30 children (mean age 27.4 months) with TBM at varying intervals during the first month of treatment. The mean concentration during the 1st week of therapy was 780 pg/ml falling to 554 pg/ml in the 2nd week, 529 pg/ml in the 3rd weak and 269 pg/ml in the 4th week. TNFα and ID-1β concentrations were determined in 23 of these children on 56 occasions. TNFα was present in low, but detectable, concentration throughout the first month of therapy with, mean concentrations of 17.15 pg/ml, 11.39 pg/ml, 11.08 pg/ml and 11.19 pg/ml in the 1st, 2nd, 3rd and 4th weeks respectively. LL-1β concentrations fell from a mean of 51.56 pg/ml to 43.1 pg/ml, 41.7 pg/ml and 17.62 pg/ml in the 2nd, 3rd and 4th weeks of therapy. The persistence of these cytokines in the CSF for a prolonged period after starting therapy indicates an immune response fundamentally different from that in bacterial meningitis. Evaluation of these cytokines and others could provide insights into the molecular pathogenesis and antiinflammatory treatment of TBM.
机译:在治疗的第一个月中,以不同的间隔对30例TBM患儿(平均年龄27.4个月)中的76次CSF INF浓度进行了测定。治疗第一周的平均浓度为780 pg / ml,第二周降至554 pg / ml,第三弱者为529 pg / ml,第四周为269 pg / ml。在这些儿童中,有23次在56次中测定了TNFα和ID-1β的浓度。在治疗的第一个月中,TNFα的浓度很低,但可检测到,在第一,第二,第三和第四周的平均浓度分别为17.15 pg / ml,11.39 pg / ml,11.08 pg / ml和11.19 pg / ml。分别。在治疗的第二,第三和第四周,LL-1β的浓度从平均51.56 pg / ml降至43.1 pg / ml,41.7 pg / ml和17.62 pg / ml。在开始治疗后,这些细胞因子在脑脊液中的持续时间较长,表明其免疫反应与细菌性脑膜炎的免疫反应根本不同。对这些细胞因子和其他细胞因子的评估可以提供有关TBM的分子发病机理和抗炎治疗的见识。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号